US public's view of pharma plummets

31 May 2001

The percentage of Americans who believe the pharmaceutical industry isdoing a good job of serving its consumers has fallen 20 points since 1997, from 79% to 59% now, according to Harris Interactive's annual tracking of public perceptions of major industries.

Public views of how other health care providers serve their customers have also declined, with 67% saying that hospitals do a good job, down from 77%, support for health insurance companies down to 39% from 55%, and appreciation for managed care companies, such as health maintenance organizations, dropping from 51% to 29%, it says.

37% of the 1,014 people polled this year for the survey told Harris that pharmaceutical companies were doing a bad job of serving their customers, as did 26% for hospitals, 57% for health insurance companies and 59% for MCOs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight